Form 4: KORU Medical Systems Insider Buys Shares

Adam R. Kalbermatten, President-Chief Commercial Officer of KORU Medical Systems, Inc., acquired 12,500 shares of common stock through two transactions on June 11, 2026.

Summary

• Adam R. Kalbermatten, President-Chief Commercial Officer of KORU Medical Systems, Inc., purchased a total of 12,500 shares of common stock on June 11, 2026.
• The first transaction involved acquiring 5,000 shares at a price of $3.96 per share.
• The second transaction involved acquiring 7,500 shares at a price of $3.93 per share.
• Following these transactions, Mr. Kalbermatten beneficially owns 312,500 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development due to the insider purchase, signaling management confidence, though the filing itself is purely transactional and lacks performance data.

Positives

• Insider buying activity, with a key executive purchasing shares, can signal confidence in the company's future prospects.
• The purchases were made at prices below $4.00, potentially indicating an attractive valuation from the executive's perspective.

Future Outlook

This filing does not contain forward-looking statements or guidance. It solely reports on a past transaction.

Management Comments

• The filing includes a standard disclaimer stating that the filing does not constitute an admission of beneficial ownership for Section 16 purposes or that the statement is legally required.
• A Power of Attorney has been previously filed, authorizing Thomas Adams as Attorney-in-Fact for the signature.

Industry Context

StockSavvy.ai notes that insider purchases, particularly by senior management, are often interpreted by the market as a positive signal of management's belief in the company's intrinsic value and future growth potential, especially in the medical device sector where innovation and market adoption are key drivers.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management's confidence in the company's stock value.
• Employees may be encouraged by the visible commitment of a senior executive to the company's success.

Key Dates

Recommendation

The filing reports an insider purchase, which is generally a positive signal. However, without accompanying financial performance data or strategic updates, it is insufficient to warrant a strong buy or sell recommendation. A 'hold' reflects the neutral stance based solely on this transactional information.

Keywords

KORU Medical Systems, KRMD, Form 4, Insider Trading, Stock Purchase, Beneficial Ownership, Adam R. Kalbermatten, President-Chief Commercial Officer